IDEXX Laboratories, Inc.
IDXX
$556.93
$11.072.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.66% | 14.26% | 14.28% | 13.29% | 10.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.66% | 14.26% | 14.28% | 13.29% | 10.55% |
| Cost of Revenue | 5.49% | 11.47% | 12.73% | 11.17% | 7.88% |
| Gross Profit | 12.14% | 15.94% | 15.33% | 14.65% | 12.21% |
| SG&A Expenses | 10.90% | 14.64% | 6.14% | 11.31% | 8.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.42% | 12.64% | 10.59% | 11.72% | 8.57% |
| Operating Income | 14.08% | 17.90% | 24.04% | 16.77% | 14.68% |
| Income Before Tax | 15.14% | 14.63% | 19.73% | 15.34% | 39.87% |
| Income Tax Expenses | 15.28% | 14.23% | 46.12% | 6.20% | 22.61% |
| Earnings from Continuing Operations | 15.11% | 14.74% | 14.82% | 17.94% | 44.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.11% | 14.74% | 14.82% | 17.94% | 44.61% |
| EBIT | 14.08% | 17.90% | 24.04% | 16.77% | 14.68% |
| EBITDA | 14.14% | 17.18% | 23.00% | 15.81% | 14.36% |
| EPS Basic | 17.24% | 17.15% | 17.62% | 21.19% | 48.60% |
| Normalized Basic EPS | 16.93% | 20.53% | 26.25% | 18.52% | 16.16% |
| EPS Diluted | 17.63% | 17.23% | 17.88% | 21.43% | 48.77% |
| Normalized Diluted EPS | 17.24% | 20.65% | 26.40% | 18.75% | 16.39% |
| Average Basic Shares Outstanding | -1.81% | -2.05% | -2.38% | -2.68% | -2.68% |
| Average Diluted Shares Outstanding | -2.08% | -2.15% | -2.49% | -2.87% | -2.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |